Mainstay Medical’s Chronic Low Back Pain Device Approved Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The company plans to launch the product in the first half of 2021. Source: Devices & Diagnostics Letter You Might Also Like Mylan’s Generic Version of Biogen’s MS Drug Gets FDA Approval August 20, 2020 FDA Grants Priority Review for Liso-Cel in B-cell Lymphoma February 24, 2020 FDA Warns Danish Drugmaker for Testing Failures March 24, 2020
